1. Home
  2. PLXS vs TMDX Comparison

PLXS vs TMDX Comparison

Compare PLXS & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLXS

Plexus Corp.

HOLD

Current Price

$150.44

Market Cap

4.0B

Sector

Technology

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$136.41

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLXS
TMDX
Founded
1979
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.9B
IPO Year
1986
2019

Fundamental Metrics

Financial Performance
Metric
PLXS
TMDX
Price
$150.44
$136.41
Analyst Decision
Buy
Buy
Analyst Count
4
10
Target Price
$157.50
$133.00
AVG Volume (30 Days)
164.5K
835.5K
Earning Date
01-21-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
56.11
170.70
EPS
6.26
2.54
Revenue
$4,032,966,000.00
$566,354,000.00
Revenue This Year
$10.99
$38.84
Revenue Next Year
$7.02
$20.43
P/E Ratio
$24.02
$53.83
Revenue Growth
1.82
41.20
52 Week Low
$103.43
$55.00
52 Week High
$172.89
$156.00

Technical Indicators

Market Signals
Indicator
PLXS
TMDX
Relative Strength Index (RSI) 60.30 54.31
Support Level $141.26 $133.50
Resistance Level $151.86 $156.00
Average True Range (ATR) 5.09 8.50
MACD 1.22 0.41
Stochastic Oscillator 88.05 55.98

Price Performance

Historical Comparison
PLXS
TMDX

About PLXS Plexus Corp.

Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: